전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-1 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,047 programs
AntibodyLimited DatastaleGenentech, Inc.Phase 3

ranibizumab (rhuFab V2, rhuFab V2 (ranibizumab))

Macular Degeneration · Macular Degeneration

#MacularDegeneration#Antibody#Phase3#monoclonal-antibody#Genentech
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

Bevacizumab (rhuMAb VEGF, rhuMAb VEGF (Bevacizumab))

Renal Cell Cancer · Renal Cell Cancer

#RenalCellCancer#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Discontinued
CGTLimited DatastaleUltragenyx Pharmaceutical IncPhase 2

scAAV8OTC (scAAV8OTC)

Ornithine Transcarbamylase (OTC) Deficiency · Ornithine Transcarbamylase (OTC) Deficie

#OrnithineTranscarbamylaseOTCDefi#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

serplulimab、bevacizumab (serplulimab、bevacizumab)

Rectal Cancer · Rectal Cancer

#RectalCancer#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Recruiting
CGTLimited DatastaleThe First Affiliated Hospital o…Phase 2

ssCART-19 cells combined with CD19+ feeding T cells (FTCs, ssCART-19 cells combined with CD19+ feeding T cells, ssCART-19 cells combined with CD19+ feeding T cells (FTCs) infusion)

Acute Lymphoblastic Leukemia, Adult B-Cell · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
AntibodyLimited DatastaleUniversity Hospital, Gentofte, …Preclinical

adalimumab (Humira, subjects will receive either infliximab, adalimumab or etanercept)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Preclinical#monoclonal-antibody#University
Trials 1Status Active
CGTLimited DatastaleTargeted Genetics CorporationPhase 3

tgAAVCF (tgAAVCF)

Cystic Fibrosis · Cystic Fibrosis

#CysticFibrosis#CGT#Phase3#cell-gene-therapy#CAR-T+2
Trials 1Status Discontinued
AntibodyLimited DatastaleEli LillyPhase 2

toripalimab + cetuximab + platinum (three cycles, three cycles (toripalimab + cetuximab + platinum))

Locally Advanced Hypopharyngeal Carcinoma · Locally Advanced Hypopharyngeal Carcinom

#LocallyAdvancedHypopharyngealCar#Antibody#Phase2#monoclonal-antibody#Eli
Trials 1Status Recruiting
AntibodyLimited DatastaleMatthew C. BakerPhase 3

LY3090106 (tibulizumab, tibulizumab (LY3090106))

Primary Sjogren's Syndrome · Primary Sjogren's Syndrome

#PrimarySjogrensSyndrome#Antibody#Phase3#monoclonal-antibody#Matthew
Trials 1Status Discontinued
AntibodyLimited DatastaleVanderbilt-Ingram Cancer CenterPreclinical

ticilimumab (ticilimumab)

Melanoma · Melanoma

#Melanoma#Antibody#Preclinical#monoclonal-antibody#Vanderbilt-Ingram
Trials 1Status Discontinued
AntibodyLimited DatastaleBeiGenePreclinical

tislelizumab, azacytidine, lenalidomide (tislelizumab, azacytidine, lenalidomide)

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type · Natural Killer/T-Cell Lymphoma, Nasal an

#NaturalKillerT-CellLymphomaNasal#Antibody#Preclinical#monoclonal-antibody#NaturalKiller+3
Trials 1Status Active
AntibodyLimited DatastaleBeiGenePreclinical

tislelizumab, etoposide, pegaspargase (tislelizumab, etoposide, pegaspargase)

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type · Natural Killer/T-Cell Lymphoma, Nasal an

#NaturalKillerT-CellLymphomaNasal#Antibody#Preclinical#monoclonal-antibody#NaturalKiller+3
Trials 1Status Active
AntibodyLimited DatastaleRocheApproved

tocilizumab [RoActemra/Actemra] (tocilizumab [RoActemra/Actemra])

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#monoclonal-antibody#Roche
Trials 1Status Discontinued
AntibodyLimited DatastaleGlaxoSmithKlinePhase 2

tositumomab (tositumomab)

Lymphoma, B-Cell · Lymphoma

#Lymphoma#Antibody#Phase2#monoclonal-antibody#B-Cell+1
Trials 1Status Active
AntibodyLimited DatastaleAstraZenecaPhase 3

anti-CTLA4 (tremelimumab, tremelimumab (anti-CTLA4))

Non - Small Cell Lung Cancer NSCLC · Non - Small Cell Lung Cancer NSCLC

#Non-SmallCellLungCancerNSCLC#Antibody#Phase3#monoclonal-antibody#AstraZeneca
Trials 1Status Active
AntibodyLimited DatastaleAstraZenecaPhase 2

treme (tremelimumab, tremelimumab (treme))

Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck · Advanced Solid Tumors & Metastatic Squam

#AdvancedSolidTumorsMetastaticSqu#Antibody#Phase2#monoclonal-antibody#AstraZeneca
Trials 1Status Active
AntibodyLimited DatastaleAstraZenecaPhase 1

durvalumab (Imfinzi, tremelimumab + durvalumab)

Advanced Malignancy · Advanced Malignancy

#AdvancedMalignancy#Antibody#Phase1#monoclonal-antibody#AstraZeneca
Trials 1Status Active
AntibodyLimited DatastaleAstraZenecaPhase 2

tremelimumab plus MEDI4736 (tremelimumab plus MEDI4736)

Pleural Mesothelioma; Peritoneal Mesothelioma · Pleural Mesothelioma

#PleuralMesothelioma#Antibody#Phase2#monoclonal-antibody#PeritonealMesothelioma+1
Trials 1Status Active
AntibodyLimited DatastaleAstraZenecaPhase 2

tremelimumab+MEDI4736 (tremelimumab+MEDI4736)

Metastatic Pancreatic Ductal Adenocarcinoma · Metastatic Pancreatic Ductal Adenocarcin

#MetastaticPancreaticDuctalAdenoc#Antibody#Phase2#monoclonal-antibody#AstraZeneca
Trials 1Status Active
CGTLimited DatastaleInstitute of Hematology & Blood…Phase 1

uCD7 CART (uCD7 CART)

Acute Myeloid Leukemia (AML); T Lymphoblastic Leukemia/Lymphoma · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting

102 / 103 pages

← PreviousNext →